Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gina M. Santorelli is active.

Publication


Featured researches published by Gina M. Santorelli.


Bioorganic & Medicinal Chemistry Letters | 1999

Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392.

Ronald W. Ratcliffe; Robert R. Wilkening; Kenneth J. Wildonger; Sherman T. Waddell; Gina M. Santorelli; D.L. Parker; Jerry D. Morgan; Timothy A. Blizzard; Milton L. Hammond; James V. Heck; Joann Huber; Joyce Kohler; Karen Dorso; E.St. Rose; Jon G. Sundelof; Walter J. May; Gail G. Hammond

A series of 1beta-methyl-2-(naphthosultamyl)methyl-carbapenems bearing dicationic groups on the naphthosultamyl moiety was prepared and evaluated for activity against resistant gram-positive bacteria. Based on a combination of excellent in vitro antibacterial activity, acceptable mouse acute toxicity, and a desirable fragmentation pattern on beta-lactam ring opening, the analog 2g (L-786,392) was selected for extended evaluation.


Tetrahedron Letters | 1996

MILD PREPARATION OF CEPHALOSPORIN ALLYL AND P-METHOXYBENZYL ESTERS USING DIAZOALKANES

Sherman T. Waddell; Gina M. Santorelli

Abstract Vinyl or p-methoxyphenyldiazomethane reacts rapidly with cephalosporins in ether/methylene chloride cosolvent to give the C-9 allyl and p-methoxybenzyl esters, respectively, in good yields, with no isomerization of the double bond to Δ-2.


Bioorganic & Medicinal Chemistry Letters | 2003

Preparation of Potential Inhibitors of the Mur-Pathway Enzymes on Solid Support Using an Acetal Linker

Milana Maletic; Jelena Antonic; Aaron H. Leeman; Gina M. Santorelli; Sherman T. Waddell

Here, we report a novel strategy for the combinatorial or parallel solid-phase synthesis of potential inhibitors of the mur-pathway enzymes. The strategy involves the efficient use of p-alkoxybenzylidene acetal linker for reversible immobilization of sugar scaffolds to solid phase. This methodology was used to synthesize several glycopeptides on solid phase in good yields.


Bioorganic & Medicinal Chemistry Letters | 2005

Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1

Susan D. Aster; Donald W. Graham; Divya Kharbanda; Gool F. Patel; Mitree M. Ponpipom; Gina M. Santorelli; Michael J. Szymonifka; Steven S. Mundt; Kashmira Shah; Marty S. Springer; Rolf Thieringer; Anne Hermanowski-Vosatka; Samuel D. Wright; Jianying Xiao; Hratch J. Zokian; James M. Balkovec


Archive | 2005

Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

Sherman T. Waddell; James M. Balkovec; Gina M. Santorelli; Aaron H. Leeman; Milana Maletic; Xin Gu


Bioorganic & Medicinal Chemistry Letters | 1998

Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: II. 6-OMe derivatives VIA clarithromycin

Sherman T. Waddell; Gina M. Santorelli; Timothy A. Blizzard; Amy C. Graham; James Occi


Bioorganic & Medicinal Chemistry Letters | 1998

Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: I. 4″, 11 and 12-OMe derivatives via direct methylation

Sherman T. Waddell; Gina M. Santorelli; Timothy A. Blizzard; Amy C. Graham; James Occi


Archive | 1999

9a-azalides, compositions containing such compounds and methods of treatment

Timothy A. Blizzard; Sherman T. Waddell; Gina M. Santorelli; Jerry D. Morgan


Archive | 2000

Novel catechols as antimicrobial agents

Aaron H. Leeman; Milton L. Hammond; Milana Maletic; Gina M. Santorelli; Sherman F. Waddell; John T. Finn; Michael Morytko; Jason Hill; Dennis Keith


Archive | 2000

Novel prolines as antimicrobial agents

Aaron H. Leeman; Milton L. Hammond; Milana Maletic; Gina M. Santorelli; Sherman F. Waddell; John T. Finn; Michael Morytko; Siya Ram; Dennis Keith

Researchain Logo
Decentralizing Knowledge